Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jun;28(3):165-73.
doi: 10.1007/s10792-007-9087-0.

Graft failure: I. Endothelial cell loss

Affiliations
Review

Graft failure: I. Endothelial cell loss

Ilse Claerhout et al. Int Ophthalmol. 2008 Jun.

Abstract

Graft failure through endothelial cell loss is a constant threat throughout the lifetime of a corneal graft. It can occur at various time points after transplantation. Primary graft failure has nowadays become increasingly rare owing to meticulous eye banking methods and improved surgical techniques. Corneal graft rejection is always held responsible for endothelial cell loss. However a rejection episode that is promptly and adequately treated does not necessarily lead to a higher than expected cell loss. A more smouldering danger to ultimate graft survival is late endothelial failure. This gradual graft decompensation is secondary to a decrease in cell density below that necessary to maintain corneal deturgesence. The process of transplantation itself seems to set off a series of events (possibly immunological) that greatly exacerbates the endothelial cell loss compared to virgin corneas. This accelerated cell loss persists for at least 10-15 years after transplantation, after which a more-stable situation is reached and cell attrition returns to normal rates. This provides a strong rationale for setting high donor standards of minimal cell density. Newer transplantation techniques such as deep anterior lamellar keratoplasty and deep lamellar endothelial keratoplasty could provide possible solutions to prevent this late endothelial failure. However they still have to prove themselves in the long run.

PubMed Disclaimer

References

    1. Arch Ophthalmol. 2004 Oct;122(10):1437-40 - PubMed
    1. Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4747-52 - PubMed
    1. Ophthalmology. 2005 Sep;112(9):1541-8 - PubMed
    1. Eye (Lond). 1995;9 ( Pt 2):247-53 - PubMed
    1. Ophthalmology. 1998 Oct;105(10):1855-65 - PubMed

LinkOut - more resources